Association Between Indole-3-Pyruvic Acid and Change in Fat-Free Mass Relative to Weight Loss in Patients Undergoing Sleeve Gastrectomy
Open Access
- 11 August 2024
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (8) , 444
Abstract
Sleeve gastrectomy typically leads to weight loss, including a reduction in fat-free mass (FFM). Studies have shown significant FFM loss within 1 year after the procedure but with individual variations. This study aimed to assess whether preoperative amino acid metabolite levels can predict FFM changes following sleeve gastrectomy. This study involved 42 patients. Body weight, fat mass (FM), and FFM were measured preoperatively and 3, 6, and 12 months postoperatively. All participants experienced weight loss, FM reduction, and FFM decrease for up to 3 months after surgery. However, the following distinct groups emerged from 3 to 6 months postoperatively: one showed FFM gain relative to weight loss, whereas the other exhibited continued FFM reduction relative to weight loss. This trend persisted for up to 12 months postoperatively and became more pronounced. The group with FFM gain had lower preoperative BMI and higher levels of indole-3-pyruvic acid (IPyA). Logistic regression and ROC curve analyses confirmed IPyA’s ability to predict FFM gain between 3 and 6 months after sleeve gastrectomy, with a useful cutoff value of 20.205. Preoperative IPyA levels were associated with FFM gain relative to weight loss in the 3 to 6 months following sleeve gastrectomy. These findings suggest that IPyA may be a potential predictor for FFM changes during this period.Keywords
Funding Information
- Yungjin Pharm. Co., Ltd., the Young Medical Scientist Research Grant through the Seokchunnanum Foundation (R2127811, 2020R1I1A1A01070106)
- Korea University Anam Hospital, Seoul, Republic of Korea, and the Basic Science Research Program through the National Research Foundation of Korea (R2127811, 2020R1I1A1A01070106)
This publication has 33 references indexed in Scilit:
- Body Composition, Sarcopenia and Physical Performance After Bariatric Surgery: Differences Between Sleeve Gastrectomy and Roux-En-Y Gastric BypassObesity Surgery, 2022
- Body Composition Differences Between Excess Weight Loss ≥ 50% and < 50% at 12 Months Following Bariatric SurgeryObesity Surgery, 2022
- Body Composition Changes Following Sleeve Gastrectomy Vs. One-Anastomosis Gastric Bypass: Tehran Obesity Treatment Study (TOTS)Obesity Surgery, 2021
- Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic OutcomesObesity Surgery, 2021
- Role of damage and management in muscle hypertrophy: Different behaviors of muscle stem cells in regeneration and hypertrophyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2020
- Metabolomic Analysis of the Improvements in Insulin Secretion and Resistance After Sleeve Gastrectomy: Implications of the Novel BiomarkersObesity Surgery, 2020
- Rate and Determinants of Excessive Fat-Free Mass Loss After Bariatric SurgeryObesity Surgery, 2020
- Definitions of Long-Term Weight Regain and Their Associations with Clinical OutcomesObesity Surgery, 2019
- Standardization of Bariatric Metabolic Procedures: World Consensus Meeting StatementObesity Surgery, 2019
- Predictors of fat-free mass loss 1 year after laparoscopic sleeve gastrectomyJournal of Endocrinological Investigation, 2018